Pages

▼
Showing posts with label nanotechnology. Show all posts
Showing posts with label nanotechnology. Show all posts
Friday, July 19, 2013

Deals Of The Week: Kicking The Tires

›
Apparently, virtually by the time it became “news,” it transformed into “non-news.” News reports of Roche’s interest in acquiring ultra...
Friday, April 05, 2013

Deals Of The Week Wonders Whether Heated Competition To Buy Ache Laboratorios Will Muddy The Brazilian Waters

›
Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories’ gargantuan purchase of ...
Friday, October 12, 2012

Deals Of The Week: Vaxxas To Help Shape The Next Generation Of Vaccines

›
Australian/U.S. biotech Vaxxas came out of stealth mode Oct. 8, announcing a deal with Merck & Co. in which the biotech’s proprietar...
Friday, December 17, 2010

2010 M&A DOTY Nominee: Celgene/Abraxis Bioscience

›
It's time for the IN VIVO Blog's Third Annual Deal of the Year! competition. This year we're presenting awards in three categori...
Thursday, August 14, 2008

FDA Thinks Small: Next Steps for Nanotech

›
When it comes to drug development, the Food & Drug Administration is starting to think small. Really small. Nanotechnology—the manipulat...
Wednesday, December 19, 2007

A Note on Nanotech and Cancer Diagnostics

›
Does anyone else sense an increase in the rate at which nanotechnology is being rationally applied to cancer diagnostics? More and more, it ...